glucagonoma syndrome

glu·ca·gon·o·ma syn·drome

necrolytic migratory erythema or intertriginous and periorofacial dermatitis, stomatitis, anemia, weight loss, and hyperglycemia resulting from glucagon-secreting pancreatic islet cell tumors.

glucagonoma syndrome

[glo̅o̅′kəgonō′mə]
Etymology: Gk, glykys + agaein + oma, tumor
a disease associated with a glucagon-secreting tumor of the islet cells of the pancreas. It is characterized by hyperglycemia, stomatitis, glossitis, anemia, weight loss, and a characteristic rash. Treatment is surgical removal of the tumor.

glucagonoma syndrome

A symptom complex associated with glucagonoma, a tumor of post-menopausal ♀ who often have DM, blistering dermatitis–necrolytic migratory erythema, epidermal necrosis, subcorneal pustules, suppurative folliculitis, confluent parakeratosis, epidermal hyperplasia, and prominent papillary dermal hyperplasia, weight loss, normochromic anemia, ileus, constipation or diarrhea, glossitis, angular cheilitis, venous thrombosis, hypoproteinemia, neuropsychiatric changes

glu·ca·gon·o·ma syn·drome

(glūkă-gon-ōmă sindrōm)
Necrolytic migratory erythema or intertriginous and periorofacial dermatitis, due to glucagon-secreting pancreatic islet cell tumors.
References in periodicals archive ?
Histologic variation in the skin lesions of the glucagonoma syndrome.
The glucagonoma syndrome and necrolytic migratory erythema: a clinical review.
The glucagonoma syndrome includes increased hepatic gluconeogenesis and hyperglycemia, muscle catabolism with associated wasting, and an unusual cutaneous eruption known as necrolytic migratory erythema, sometimes with associated stomatitis or cheilosis.